Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy? [electronic resource]
Producer: 20000331Description: 391-5; discussion 395-6 p. digitalISSN:- 1527-9995
- Adult
- Aged
- Aged, 80 and over
- Androgen Antagonists -- administration & dosage
- Anilides -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Flutamide -- administration & dosage
- Gonadotropin-Releasing Hormone -- agonists
- Goserelin -- administration & dosage
- Humans
- Leuprolide -- administration & dosage
- Male
- Middle Aged
- Nitriles
- Prostatic Neoplasms -- drug therapy
- Survival Rate
- Tosyl Compounds
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.